本页面由Tiger Trade Technology Pte. Ltd.提供服务

SAB Biotherapeutics, Inc.

2.83
-0.1500-5.03%
成交量:22.81万
成交额:66.10万
市值:2.57亿
市盈率:-1.82
高:2.99
开:2.97
低:2.80
收:2.98
52周最高:5.15
52周最低:2.10
股本:9,098.64万
流通股本:6,204.34万
量比:0.31
换手率:0.37%
股息:- -
股息率:- -
每股收益(TTM):-1.5562
每股收益(LYR):-0.7944
净资产收益率:-11.27%
总资产收益率:-33.46%
市净率:1.20
市盈率(LYR):-3.56

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/07

重要事件披露

Form 8-K - Current report
2026/06/19

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/22

重要事件披露

Form 8-K - Current report
2026/03/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/19

重要事件披露

Form 8-K - Current report
2026/03/10

重要事件披露

Form 8-K - Current report